IGC vs RMD · rev $869.0K vs P/E 29, rev $5.65B
India Globalization Capital Inc (IGC) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
India Globalization Capital Inc (IGC) is a biotechnology company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported IGC revenue for 2025-12-31 was $869.0K. Net income was -$4.1M. Revenue was down 31.6% from 2025-03-31 to 2025-12-31. IGC currently screens at market cap $24.1M.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
IGC currently screens at market cap $24.1M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the IGC and RMD stock pages for the full models.
Not investment advice.